Showing 1621-1630 of 2042 results for "".
- Wolfgang Haigis—Scientist Known for His Formulae—Dies at 72https://modernod.com/news/wolfgang-haigis-scientist-known-for-his-formulae-dies-at-72/2477025/The German Society for Cataract and Refractive Surgery (DGII) has announced that Prof. Dr. Wolfgang Haigis, a physicist working at the University of Wurzburg, died on October 15 at the age of 72. Dr. Haigis was a pioneer and a driving force in the development and the refinement of biometry
- Bausch + Lomb Introduces Preservision AREDS 2 Formula Minigel Eye Vitaminshttps://modernod.com/news/bausch-lomb-introduces-preservision-areds-2-formula-minigel-eye-vitamins/2477024/Bausch + Lomb announced the U.S. launch of PreserVision AREDS 2 Formula minigel eye vitamins. The new minigels will replace the currently offered PreserVision AREDS 2 Formula soft gels, offering patients an easier-to-swallow option as compared to the original AREDS 2 soft gels. PreserVision AREDS
- Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percenthttps://modernod.com/news/bio-tissue-expands-national-footprint-ramps-up-sales-force-by-more-than-25-percent-2/2476882/Bio-Tissue, a TissueTech company, announced the expansion of its sales force to more effectively meet the needs of clinicians and their patients. “A growing body of scientific evidence has cemented CAM as a mainstay treatment for ocular surface diseases,” Grady Grant III, TissueTech Vice P
- Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percenthttps://modernod.com/news/bio-tissue-expands-national-footprint-ramps-up-sales-force-by-more-than-25-percent/2479535/Bio-Tissue, a subsidiary of TissueTech, announced the expansion of its sales force to more effectively meet the needs of clinicians and their patients. “A growing body of scientific evidence has cemented CAM as a mainstay treatment for ocular surface diseases,” Grady Grant III, TissueTech
- Maui Jim and VSP Global Expand Relationship to Include Maui Jim Inside the VSP Formularyhttps://modernod.com/news/maui-jim-and-vsp-global-expand-relationship-to-include-maui-jim-inside-the-vsp-formulary/2479547/Maui Jim, the sunglass and eyewear supplier, announced “a significant step forward in its ongoing relationship with VSP Global,” reporting that Maui Jim will officially be available within the VSP formulary and will be included in the VSP contract lab network, according to a VisionMon
- Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Anti-Microbial Ophthalmic and Otic Therapeuticshttps://modernod.com/news/harrow-health-forms-stowe-pharmaceuticals-subsidiary-to-develop-anti-microbial-ophthalmic-and-otic-therapeutics/2479553/Harrow Health announced that its newly formed subsidiary, Stowe Pharmaceuticals, has entered into an agreement with TGV Health to acquire worldwide rights to the Zian anti-microbial molecule for ophthalmic and otic uses. Zian is a patented small molecule that is water soluble, colorless,
- Notal Vision Diagnostic Clinic Reports Completion of 6 Million ForeseeHome AMD Home-Monitoring Testshttps://modernod.com/news/notal-vision-diagnostic-clinic-reports-completion-of-6-million-foreseehome-amd-home-monitoring-tests/2476750/Notal Vision announced the completion of 6 million patient tests performed with ForeseeHome, the first FDA-cleared home-monitoring device for patients with intermediate dry age-related macular degeneration (AMD) at risk for developing wet AMD, according to a company news release. ForeseeHo
- Promedica International and Dr. Agarwal’s Eye Hospitals Form Strategic Alliancehttps://modernod.com/news/promedica-international-and-dr-agarwals-eye-hospitals-form-strategic-alliance-2/2476709/Promedica International (PMI) and Dr. Agarwal’s Eye Hospitals (AEH) have formed a new partnership to conduct clinical trials in India. PMI and AEH stated that the alliance will enable them to collaboratively enroll and manage clinical studies in an expanded patient population, while conforming wi
- Promedica International and Dr. Agarwal’s Eye Hospitals Form Strategic Alliancehttps://modernod.com/news/promedica-international-and-dr-agarwals-eye-hospitals-form-strategic-alliance/2476696/Promedica International (PMI) and Dr. Agarwal’s Eye Hospitals (AEH) have formed a new partnership to conduct clinical trials in India, which they announced at the OCTANe Ophthalmology Technology Summit. PMI and AEH em
- Aerpio Initiates Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucomahttps://modernod.com/news/aerpio-initiates-phase-1b-clinical-trial-of-topical-ocular-formulation-of-akb-9778-for-primary-open-angle-glaucoma/2476645/Aerpio Pharmaceuticals dosing of the first subject in a phase 1b trial of a topical ocular formulation of AKB-9778 in development for treatment of primary open angle glaucoma (POAG). The phase 1 study is a double-masked, multiple-ascending dose trial and will enroll four cohorts of 12 subj